Literature DB >> 2844921

Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.

M A Jacobson1, S Crowe, J Levy, F Aweeka, J Gambertoglio, N McManus, J Mills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2844921

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

Review 1.  Antiretroviral therapy: reverse transcriptase inhibition.

Authors:  K J Connolly; S M Hammer
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.

Authors:  A M Taburet; C Katlama; C Blanshard; G Zorza; D Gazzard; E Dohin; B G Gazzard; C Frostegard; E Singlas
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

3.  Efficacy and effects on pulmonary function tests of weekly 600 mg aerosol pentamidine as prophylaxis against Pneumocystis carinii pneumonia.

Authors:  E L Ong; E M Dunbar; B K Mandal
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 4.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 5.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

Authors:  A K Field; K K Biron
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

6.  Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates.

Authors:  J W Mellors; H Z Bazmi; R F Schinazi; B M Roy; Y Hsiou; E Arnold; J Weir; D L Mayers
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

7.  Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet.

Authors:  R F Omar; N Dusserre; A Désormeaux; L Poulin; M Tremblay; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Antineurofilament and antiretinal antibodies in AIDS patients with cytomegalovirus retinitis.

Authors:  D F Rosberger; S L Tshering; B Polsky; M H Heinemann; R F Klein; S Cunningham-Rundles
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

9.  Foscarnet for suppression of human immunodeficiency virus replication.

Authors:  C V Fletcher; A C Collier; F S Rhame; D Bennett; M F Para; C C Beatty; C E Jones; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

10.  Age-related differences in phosphonoformate-induced bone toxicity in cats.

Authors:  C L Swenson; S E Weisbrode; L A Nagode; K A Hayes; C L Steinmeyer; L E Mathes
Journal:  Calcif Tissue Int       Date:  1991-05       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.